LRA Welcomes Positive Results with Anifrolumab for Reducing Lupus Flares
May 13, 2021 A new study analyzing data from two large clinical trials showed that the investigational therapy anifrolumab reduced flares in people with moderate to severe lupus while allowing lowered steroid use. The study was published in the professional journal Lupus by top lupus researchers, several of whom are leaders in the Lupus Clinical […] Read More